rs1554562278
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001382391.1(CSPP1):c.255_256del(p.His85GlnfsTer24) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000362 in 1,379,998 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000036 ( 0 hom. )
Consequence
CSPP1
NM_001382391.1 frameshift
NM_001382391.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.19
Genes affected
CSPP1 (HGNC:26193): (centrosome and spindle pole associated protein 1) This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 8-67086060-CAT-C is Pathogenic according to our data. Variant chr8-67086060-CAT-C is described in ClinVar as [Pathogenic]. Clinvar id is 100673.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-67086060-CAT-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CSPP1 | NM_001382391.1 | c.255_256del | p.His85GlnfsTer24 | frameshift_variant | 4/31 | ENST00000678616.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CSPP1 | ENST00000678616.1 | c.255_256del | p.His85GlnfsTer24 | frameshift_variant | 4/31 | NM_001382391.1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 genomes
?
Cov.:
32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249318Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135284
GnomAD3 exomes
AF:
AC:
1
AN:
249318
Hom.:
AF XY:
AC XY:
0
AN XY:
135284
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000362 AC: 5AN: 1379998Hom.: 0 AF XY: 0.00000145 AC XY: 1AN XY: 691240
GnomAD4 exome
AF:
AC:
5
AN:
1379998
Hom.:
AF XY:
AC XY:
1
AN XY:
691240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? Cov.: 32
GnomAD4 genome
?
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Joubert syndrome 21 Pathogenic:5Other:1
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Jan 29, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jul 19, 2022 | ClinVar contains an entry for this variant (Variation ID: 100673). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with Joubert syndrome (PMID: 24360803, 26092869). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs587777144, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.His121Glnfs*22) in the CSPP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CSPP1 are known to be pathogenic (PMID: 24360807, 24360808). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 02, 2014 | - - |
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | Apr 25, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at